Chemical Compound
Lisinopril dihydrate
CAS Registry Number
83915-83-7
Primary Record
Lisinopril dihydrate
- In stock
- 7,849 g
- Purity
- 99.0 %
- CAS
- 83915-83-7
Compound Identifiers & Properties
- CAS
- 83915-83-7
- PubChem CID
- 5362118
- SMILES
- C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O.O.O
- Canonical SMILES
- NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O
Names & Synonyms
- Lisinopril dihydrate
- lisinopril
- Renacor
- Prinivil
- Ranolip
- Zestril
- 83915-83-7
- Lisinopril hydrate
- Prinzide
- (S)-Lisinopril
- Lysinopril
- Zestoretic
- Qbrelis
- Mixture Name
- lisinopril-dihydrat
- Prinivil (TN)
- Lisinopril (USP)
- Prestwick_613
- Zestril (TN)
- Lisinopril (dihydrate)
- Lisinopril(Dihydrate)
- AC1NSFPC
- Lisinopril dihydrate CRS
- MFCD01698825
- RefChem:799369
- LISINOPRIL [HSDB]
- LISINOPRIL [USAN]
- UNII-E7199S1YWR
- (S)-Lisinopril Dihydrate
- DTXSID2045600
- MK-521
- LISINOPRIL [MART.]
- E7199S1YWR
- LISINOPRIL [USP-RS]
- Lisinopril hydrate (JP18)
- DTXCID0025600
- HSDB 6852
- LISINOPRIL DIHYDRATE [MI]
- SCHEMBL542591
- C21H31N3O5.2H2O
- CHEBI:6503
- CHEMBL419213
- Lisinopril [USAN:INN:BAN:JAN]
- orb1310366
- LISINOPRIL [ORANGE BOOK]
- LISINOPRIL HYDRATE [JAN]
- Lisinopril, >=98% (HPLC)
- MSK10889W
- LISINOPRIL [USP IMPURITY]
- CZRQXSDBMCMPNJ-ZUIPZQNBSA-N
- LISINOPRIL DIHYDRATE [WHO-DD]
- Lisinopril for peak identification
- C21H31N3O5
- C21H35N3O7
- GLXC-03927
- HMS1568N04
- HMS2095N04
- HMS3712N04
- HY-18206AR
- Lisinopril (dihydrate) (Standard)
- LISINOPRIL [USP MONOGRAPH]
- Lisinopril [USAN:BAN:INN:JAN]
- Lisinopril for system suitability A
- NSC-751176
- NSC-758151
- Lisinopril [USAN:USP:INN:BAN:JAN]
- PRINZIDE COMPONENT LISINOPRIL
- Deferasirox bis salicylamide impurity
- Tox21_110798
- (S)-Lisinopril - Bio-X trade mark
- EBC-84054
- HY-18206A
- NCGC00017141-01
- ZESTORETIC COMPONENT LISINOPRIL
- AKOS015950799
- Lisinopril for peak identification CRS
- Tox21_110798_1
- AC-6226
- AN-6585
- CCG-220301
- CID5362118
- CS-2444
- CS-O-05581
- FL24908
- KS-1078
- NSC 751176
- NSC 758151
- CAS-83915-83-7
- Lisinopril for system suitability A CRS
- NCGC00179623-04
- BL164629
- C21-H31-N3-O5.2H2-O
- H528
- SC-25401
- SY105945
- LISINOPRIL DIHYDRATE [EP MONOGRAPH]
- AB1004847
- LS-118900
- 2589H
- B3290
- FT-0627877
- ST24047491
- D00362
- F20515
- L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, dihydrate
- 915L837
- A840684
- EN300-19652794
- SR-01000801314
- Lisinopril for peak identification CRS (Y0001701)
- N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate
- SR-01000801314-3
- (S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
- (S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
- Lisinopril for System Suitability A CRS (Y0001709)
- Q47495698
- (S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid dihydrate
- (S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
- 1-(N(sup 2)-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
- 1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline
- L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)
- ((S)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline dihydrate
- (S)-1-[N2-(1-Carboxy-3-phenylpropyl)-lysyl-proline dihydrate
- L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-
- Lisinopril, United States Pharmacopeia (USP) Reference Standard
- S)-1-[N2-(1-carboxy-3-phenylpropyl)-lysyl-proline dihydrate
- (S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate
- L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-
- L-Proline,1-(N2(1-carboxy-3-phenylpropyl)-L-lysyl)-dihydrate,(S)
- Lisinopril dihydrate, British Pharmacopoeia (BP) Reference Standard
- Lisinopril dihydrate, European Pharmacopoeia (EP) Reference Standard
- N(2)-((1S)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline dihydrate
- 1-(N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate
- Lisinopril, Pharmaceutical Secondary Standard; Certified Reference Material
- N~2~-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline--water (1/2)
- L-Proline, 1-(N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-
- Lisinopril for peak identification, European Pharmacopoeia (EP) Reference Standard
- Lisinopril for system suitability A, European Pharmacopoeia (EP) Reference Standard
- (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid dihydrate
- (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;dihydrate
- (2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid dihydrate
- (2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid dihydrate
- (S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylicaciddihydrate
- 76547-98-3
- Lisinopril Dihydrate; N2-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate; (S)-1-[N2-(1-Carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate